NVP Associates, LLC

CIK 0001545692 · MENLO PARK, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-07 · Open the SEC source ↗

NVP Associates, LLC reported 7 positions worth $328.2M as of June 30, 2026 (13F filed August 7, 2026). Largest holding: MBX (35.9%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.

$328.2M

2026 Q2

Positions

Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.

100.0%

Est. Net Flow (Q)

—

2026 Q2

Positions Changes Mix History BacktestPRO

7 positions shown

#	Symbol	Company	Type	Value ↓	% Port.	Shares	1Y	YTD
▸ 1	MBX	MBX BIOSCIENCES INC	SH	$117.9M	35.93%	2,136,335	—	—
▸ 2	AVLN	AVALYN PHARMACEUTICALS INC	SH	$74.7M	22.75%	2,268,404	—	—
▸ 3	OMDA	OMADA HEALTH INC	SH	$55.6M	16.93%	2,531,000	—	—
▸ 4	ZBIO	ZENAS BIOPHARMA INC	SH	$46.7M	14.22%	1,838,482	—	—
▸ 5	SNOW	SNOWFLAKE INC	SH	$29.2M	8.90%	114,786	—	—
▸ 6	GROV	GROVE COLLABORATIVE HOLD INC	SH	$4.0M	1.23%	3,225,097	—	—
▸ 7	ONDS	ONDAS INC	SH	$128.6K	0.04%	15,602	—	—

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does NVP Associates, LLC hold as of Q2 2026?

NVP Associates, LLC reported 7 positions worth $328.2M in its Q2 2026 13F filing. Largest positions: MBX (35.9%), AVLN (22.8%), OMDA (16.9%), ZBIO (14.2%) and SNOW (8.9%).

What did NVP Associates, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did NVP Associates, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.